R-Tech Ueno (JASDAQ: 4573) has announced today that it has been notified by the International Court of Arbitration, International Chamber of Commerce (ICC), that the anticipated date of the arbitration decision in its demand for arbitration together with Sucampo Pharmaceuticals, Inc. ("Sucampo") and Sucampo AG against Takeda Pharmaceuticals Company Limited has been extended to May 31, 2012.
AboutR-Tech
Ueno, Ltd.
R-Tech Ueno is a bio venture company established
in September 1989 for the purpose of R&D and marketing of drugs. Under
leadership of the CEO, also a medical doctor, the company is developing
new drugs on the theme "Physician-Oriented New Drug Innovation",
targeting ophthalmologic and dermatologic diseases that previously had
no effective therapeutic agent.
We aim at becoming a "global
pharmaceutical company specializing in specific fields (ophthalmology
and dermatology) and developing pharmaceutical products through the eyes
of doctors and selling." We are promoting development of new drugs of
unmet medical needs (medical needs that are not fulfilled yet) which the
government recommends and assists, orphan drugs and the drugs in the
field of anti-aging (lifestyle drugs).
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals,
Inc. is an international biopharmaceutical company focused on the
development and commercialization of medicines based on prostones. The
therapeutic potential of prostones, which occur naturally in the human
body as a result of enzymatic, 15-PGDH, transformation of certain fatty
acids, was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo
Pharmaceuticals' Chairman and Chief Executive Officer. Dr. Ueno founded
Sucampo Pharmaceuticals in 1996 with Kuno, Ph.D., founding Chief
Executive Officer and currently Advisor, International Business
Development and a member of the Board of Directors.
For more
information about Sucampo Pharmaceuticals, please visit www.sucampo.com.
Contacts:
R-Tech Ueno, Ltd.
Koji Nakamura, +81-3-3596-8011
Director
Business
Management Department
info@rtueno.co.jp
